Cargando…
CD5, an Undercover Regulator of TCR Signaling
T cells are critical components of adaptive immunity. As such, their activation is regulated by the T cell receptor (TCR) that constantly scan peptides associated with major histocompatibility complexes (MHC). TCR engagement initiates a series of molecular events leading to cytokine secretion, proli...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292949/ https://www.ncbi.nlm.nih.gov/pubmed/30581443 http://dx.doi.org/10.3389/fimmu.2018.02900 |
_version_ | 1783380464730374144 |
---|---|
author | Voisinne, Guillaume Gonzalez de Peredo, Anne Roncagalli, Romain |
author_facet | Voisinne, Guillaume Gonzalez de Peredo, Anne Roncagalli, Romain |
author_sort | Voisinne, Guillaume |
collection | PubMed |
description | T cells are critical components of adaptive immunity. As such, their activation is regulated by the T cell receptor (TCR) that constantly scan peptides associated with major histocompatibility complexes (MHC). TCR engagement initiates a series of molecular events leading to cytokine secretion, proliferation, and differentiation of T cells. As a second coincident event, activation of co-stimulatory molecules, such as CD28, synergize with the TCR in order to prolong and/or amplify intracellular signals. With the recent advances in immunotherapies targeting T cells, co-inhibitory receptors are of growing interest for immunologists due to their potential modulatory properties on T cell functions. However, special attention should be dedicated to avoid unwanted clinical outcomes (1). In particular, Manichean categorization of receptors based on incomplete functional knowledge can lead to an over-simplistic view of complex cellular regulations. Thus, analysis of the functions that characterize these receptors in diverse physiological contexts remains essential for their rational use in therapeutic protocols. Here we focus on CD5, a transmembrane receptor that regulates T cell functions and development but remains poorly characterized at the molecular level. We will review its roles in physiological conditions and suggest potential molecular effectors that could account for CD5-dependent regulation of TCR signaling. |
format | Online Article Text |
id | pubmed-6292949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62929492018-12-21 CD5, an Undercover Regulator of TCR Signaling Voisinne, Guillaume Gonzalez de Peredo, Anne Roncagalli, Romain Front Immunol Immunology T cells are critical components of adaptive immunity. As such, their activation is regulated by the T cell receptor (TCR) that constantly scan peptides associated with major histocompatibility complexes (MHC). TCR engagement initiates a series of molecular events leading to cytokine secretion, proliferation, and differentiation of T cells. As a second coincident event, activation of co-stimulatory molecules, such as CD28, synergize with the TCR in order to prolong and/or amplify intracellular signals. With the recent advances in immunotherapies targeting T cells, co-inhibitory receptors are of growing interest for immunologists due to their potential modulatory properties on T cell functions. However, special attention should be dedicated to avoid unwanted clinical outcomes (1). In particular, Manichean categorization of receptors based on incomplete functional knowledge can lead to an over-simplistic view of complex cellular regulations. Thus, analysis of the functions that characterize these receptors in diverse physiological contexts remains essential for their rational use in therapeutic protocols. Here we focus on CD5, a transmembrane receptor that regulates T cell functions and development but remains poorly characterized at the molecular level. We will review its roles in physiological conditions and suggest potential molecular effectors that could account for CD5-dependent regulation of TCR signaling. Frontiers Media S.A. 2018-12-07 /pmc/articles/PMC6292949/ /pubmed/30581443 http://dx.doi.org/10.3389/fimmu.2018.02900 Text en Copyright © 2018 Voisinne, Gonzalez de Peredo and Roncagalli. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Voisinne, Guillaume Gonzalez de Peredo, Anne Roncagalli, Romain CD5, an Undercover Regulator of TCR Signaling |
title | CD5, an Undercover Regulator of TCR Signaling |
title_full | CD5, an Undercover Regulator of TCR Signaling |
title_fullStr | CD5, an Undercover Regulator of TCR Signaling |
title_full_unstemmed | CD5, an Undercover Regulator of TCR Signaling |
title_short | CD5, an Undercover Regulator of TCR Signaling |
title_sort | cd5, an undercover regulator of tcr signaling |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292949/ https://www.ncbi.nlm.nih.gov/pubmed/30581443 http://dx.doi.org/10.3389/fimmu.2018.02900 |
work_keys_str_mv | AT voisinneguillaume cd5anundercoverregulatoroftcrsignaling AT gonzalezdeperedoanne cd5anundercoverregulatoroftcrsignaling AT roncagalliromain cd5anundercoverregulatoroftcrsignaling |